Expert Consensus on Rheumatic Immune Diseases Responding Specifically to Traditional Chinese Medicine
10.13422/j.cnki.syfjx.20220995
- VernacularTitle:中医药治疗风湿免疫领域临床优势病种的探讨
- Author:
Yuan XU
1
;
Jing LUO
1
;
Man HAN
2
;
Meng-tao LI
3
;
Xiu-juan HOU
4
;
Di WU
3
;
Bin LI
5
;
Yan GENG
6
;
Yun-shan ZHOU
7
;
Chang-hong LI
8
;
Kun-peng LI
9
;
Jia-bo WANG
10
;
Yong WANG
11
;
Xiao-xiao ZHANG
12
;
Qing-wen TAO
1
Author Information
1. China-Japan Friendship Hospital，Beijing 100029，China
2. Guanganmen Hospital，China Academy of Chinese Medical Sciences，Beijing 100053，China
3. Peking Union Medical College Hospital，China Academy of Medical Sciences，Beijing 100730，China
4. Dongfang Hospital，Beijing University of Chinese Medicine，Beijing 100078，China
5. Xiyuan Hospital，China Academy of Chinese Medical Sciences，Beijing 100091，China
6. Peking University First Hospital，Beijing 100034，China
7. Peking University People's Hospital，Beijing 100044，China
8. Peking University Third Hospital，Beijing 100191，China
9. Chinese People's Liberation Army General Hospital，Beijing 100039，China
10. School of Chinese Medicine，Capital Medical University，Beijing 100013，China
11. School of Traditional Chinese Medicine，Beijing University of Chinese Medicine，Beijing 100029，China
12. China Association of Chinese Medicine，Beijing 100029，China
- Publication Type:Journal Article
- Keywords:
rheumatology and immunology department;
dominant disease;
integrated traditional Chinese and western medicine;
expert advice
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2022;28(9):198-204
- CountryChina
- Language:Chinese
-
Abstract:
In the clinical practice of rheumatic immune diseases in traditional Chinese medicine （TCM），it`s still unclear about the dominant diseases and breakthrough points. It`s urgent missions to formulate TCM diagnosis and treatment guidelines widely recognized and integrated by traditional Chinese medicine and Western medicine. In order to clarify the dominant diseases and breakthrough points in rheumatism，China association of Chinese medicine initiated a research group covering experts in the field of rheumatism of traditional Chinese medicine and Western medicine. Based on questionnaire survey and on-site discussion，experts had reached the following consensus. Evidence-based medicine research using modern medical methods and scientific methods should be carried out to provide objective clinical evidences. "Four mutuality" were put forward as the basis for the work of integrated traditional Chinese and Western medicine，that is the mutual communication using the exchangeable context，the mutual explanation using common theories，the mutual certification using common standards，and the mutual integration using common means. Key works should focus on solving refractory rheumatism in the future. In terms of dominant diseases and breakthrough points，this paper introduces 21 breakthrough points in 6 dominant diseases，including rheumatoid arthritis，ankylosing spondylitis，Sjogren's syndrome，hyperuricemia and gout，systemic lupus erythematosus and fibromyalgia syndrome. Advice on this discussion can provide valuable references for developing the treatment scheme of rheumatism with TCM and integrated Chinese and Western medicine and clinical practice and scientific research.
